Your browser doesn't support javascript.
loading
N-Ethylhexedrone: A very long and bad trip! A case series.
Lefeuvre, Sandrine; Richeval, Camille; Lelong, Jeremy; Venisse, Nicolas; Humbert, Luc; Brunet, Bertrand.
Afiliação
  • Lefeuvre S; Toxicology and Pharmacokinetics Laboratory, University Hospital, 2 Rue de la Miletrie, Poitiers, 86021, France.
  • Richeval C; INSERM CIC 1402, CHU Poitiers, CNRS 7267 EBI, University of Poitiers, 2 Rue de la Miletrie, Poitiers 86000, France.
  • Lelong J; CHU Lille, Unité Fonctionnelle de Toxicologie, Boulevard du Pr Leclercq, Lille 59037, France.
  • Venisse N; ULR 4483-IMPECS-IMPact de L'Environnement Chimique Sur La Santé Humaine, University of Lille, Boulevard du Pr Leclercq, Lille 59037, France.
  • Humbert L; Toxicology and Pharmacokinetics Laboratory, University Hospital, 2 Rue de la Miletrie, Poitiers, 86021, France.
  • Brunet B; Toxicology and Pharmacokinetics Laboratory, University Hospital, 2 Rue de la Miletrie, Poitiers, 86021, France.
J Anal Toxicol ; 48(7): 507-513, 2024 Aug 21.
Article em En | MEDLINE | ID: mdl-38794952
ABSTRACT
N-ethylhexedrone (NEH) is a new cathinone derivative with, currently, low toxicokinetic and toxicodynamic knowledge. We present three documented clinical cases of NEH intoxication with plasma and urine concentrations. A thorough search for metabolites was performed. The three patients were admitted to the emergency department, and two out of the three were hospitalized for an extended period. While recovering from the drug effects, 12-24 h after nasal intake of New Psychoactive Substance (NPS), the patients described the following disorders anxiety, feelings of persecution, asthenia, anhedonia, abulia, psychomotor slowing and loss of consciousness. NEH was identified in all samples by liquid chromatography-high resolution mass spectrometry (LC-HRMS), and quantified by liquid chromatography coupled to tandem mass spectrometry (LC-MS-MS). Quantitative analysis showed decreasing concentrations over time for Case 1, from 97.2 (Day 1, D1) to 0.7 (Day 7, D7) µg/L for plasma, and from 724 (D1) to 0.5 (D7) µg/L for urine. NEH concentration of 7.9 µg/L was found in the plasma collected at admission for Case 2. For Case 3, concentrations ranging from 49 (D1) to 1.8 (D7) µg/L in plasma, and from 327.3 (Day 6, D6) to 116.8 (D7) µg/L in urine were found. NEH was no longer detected in the urine sample at Day 10. Elimination half-life was estimated at 19, and 28 hours in Patients 1 and 3, respectively. Four metabolites were identified in blood and urine reduced NEH, dealkyl-NEH, reduced dealkyl-NEH and hydroxy-NEH. The cases presented highlight the long detectable lifetime of NEH. Characterization of the metabolites will allow better identification of the consumption of this drug. Serious adverse events can be observed after NEH consumption, as two out of the three patients required intubation and ventilation. A syndrome of inappropriate antidiuretic hormone secretion (SIADH) was also diagnosed. Two out of the three cases are notable because of the number of samples collected and because NEH was the only drug of abuse detected.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espectrometria de Massas em Tandem Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espectrometria de Massas em Tandem Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article